Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$592.2 - $792.28 $66,326 - $88,735
-112 Reduced 0.58%
19,207 $14.9 Million
Q4 2023

Feb 07, 2024

SELL
$525.19 - $619.13 $15,230 - $17,954
-29 Reduced 0.15%
19,319 $11.3 Million
Q3 2023

Nov 13, 2023

SELL
$434.7 - $599.3 $31,298 - $43,149
-72 Reduced 0.37%
19,348 $10.4 Million
Q2 2023

Jul 24, 2023

BUY
$350.74 - $468.98 $40,685 - $54,401
116 Added 0.6%
19,420 $9.11 Million
Q1 2023

May 09, 2023

SELL
$310.63 - $364.82 $105,924 - $124,403
-341 Reduced 1.74%
19,304 $6.63 Million
Q4 2022

May 09, 2023

SELL
$321.55 - $374.67 $63,988 - $74,559
-199 Reduced 1.0%
19,645 $7.19 Million
Q3 2022

Nov 14, 2022

BUY
$296.48 - $337.87 $118,888 - $135,485
401 Added 2.06%
19,844 $210,000
Q2 2022

Aug 10, 2022

SELL
$278.73 - $327.27 $3.39 Million - $3.98 Million
-12,163 Reduced 38.48%
19,443 $77,000
Q1 2022

May 16, 2022

SELL
$234.69 - $291.66 $41,070 - $51,040
-175 Reduced 0.55%
31,606 $95,000
Q4 2021

Feb 15, 2022

BUY
$224.85 - $279.04 $1,573 - $1,953
7 Added 0.02%
31,781 $140,000
Q3 2021

Nov 15, 2021

BUY
$221.6 - $272.71 $1,551 - $1,908
7 Added 0.02%
31,774 $116,000
Q2 2021

Aug 16, 2021

BUY
$180.55 - $233.54 $48,567 - $62,822
269 Added 0.85%
31,767 $113,000
Q1 2021

May 13, 2021

BUY
$164.32 - $212.72 $5.18 Million - $6.7 Million
31,498 New
31,498 $42,000
Q4 2020

Feb 16, 2021

SELL
$130.46 - $172.63 $28,309 - $37,460
-217 Closed
0 $0
Q3 2020

Nov 10, 2020

SELL
$146.22 - $169.13 $415,849 - $481,005
-2,844 Reduced 92.91%
217 $32,000
Q2 2020

Aug 13, 2020

SELL
$136.42 - $164.18 $106,271 - $127,896
-779 Reduced 20.29%
3,061 $503,000
Q1 2020

May 12, 2020

BUY
$119.05 - $147.35 $443,104 - $548,436
3,722 Added 3154.24%
3,840 $533,000
Q4 2019

Feb 11, 2020

BUY
$106.92 - $132.43 $3,528 - $4,370
33 Added 38.82%
118 $16,000
Q3 2019

Nov 12, 2019

SELL
$106.79 - $116.16 $213 - $232
-2 Reduced 2.3%
85 $9,000
Q2 2019

Aug 06, 2019

SELL
$110.79 - $129.32 $6,758 - $7,888
-61 Reduced 41.22%
87 $10,000
Q1 2019

May 15, 2019

BUY
$111.31 - $131.02 $8,682 - $10,219
78 Added 111.43%
148 $19,000
Q4 2018

Feb 11, 2019

BUY
$105.9 - $118.64 $317 - $355
3 Added 4.48%
70 $8,000
Q3 2018

Nov 13, 2018

BUY
$85.86 - $107.31 $5,752 - $7,189
67 New
67 $7,000
Q2 2018

Aug 13, 2018

SELL
$75.7 - $86.88 $1.93 Million - $2.22 Million
-25,531 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$74.21 - $87.6 $44,451 - $52,472
599 Added 2.4%
25,531 $1.98 Million
Q4 2017

May 14, 2018

BUY
$81.94 - $87.89 $2.04 Million - $2.19 Million
24,932
24,932 $2.11 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $749B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Altshuler Shaham LTD Portfolio

Follow Altshuler Shaham LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Altshuler Shaham LTD, based on Form 13F filings with the SEC.

News

Stay updated on Altshuler Shaham LTD with notifications on news.